Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Cancer Treatment
100%
European Organizations
95%
Meta-analysis
80%
95% Confidence Interval
68%
Severe Malnutrition
66%
Cancer Clinical Trials
58%
Eastern Democratic Republic of Congo
53%
EORTC
53%
Radiotherapy
41%
Clinical Trials
41%
Localized Prostate Cancer
40%
Prostate Cancer
38%
Clinical Research
33%
MUACZ
32%
Androgen Deprivation Therapy
31%
Hodgkin Lymphoma
29%
Hazard Ratio
29%
Belgium
28%
Meta-research
28%
Advanced or Metastatic
28%
In Cancer
27%
Phase II Trial
27%
Limited-stage
26%
Sustained Release Pellets
26%
Soft Tissue Sarcoma
26%
Child nutrition
26%
Pooled Analysis
26%
Bone Sarcoma
26%
Pediatric Oncology
26%
Progression-free Survival
26%
Mid-upper Arm Circumference
23%
Randomized Trial
23%
Overall Survival
21%
Diagnostic Accuracy
21%
Quality of Life
20%
5-flucytosine
20%
Dutch
18%
Intermediate Risk
18%
South Kivu
17%
Metastasis-free Survival
17%
Diagnostic Test
17%
Radiotherapy Dose
17%
Individual Patient Data
17%
Cryptococcal Meningitis
16%
Pellet Formulation
16%
Children Aged 6-59 Months
16%
New Benchmark
16%
Africa
16%
People Living with HIV (PLHIV)
16%
Treatment Intensification
16%
Medicine and Dentistry
Cancer Treatment
80%
Meta-Analysis
66%
Prostate Cancer
66%
Malignant Neoplasm
66%
Radiation Therapy
62%
Clinical Trial
46%
Arm
43%
Diseases
38%
Clinical Research
34%
Androgen Deprivation Therapy
29%
Progression Free Survival
29%
Overall Survival
27%
Cohort Analysis
27%
Hazard Ratio
26%
Hodgkin's Lymphoma
26%
Pooled Analysis
26%
Soft Tissue Sarcoma
26%
Childhood Cancer
26%
Osteosarcoma
26%
Adolescence
22%
Malnutrition
20%
Diagnostic Accuracy
19%
Prevalence
19%
Radiation Dose Escalation
18%
Prostate Specific Antigen
17%
Phase II Trials
16%
Survival Rate
16%
Chemotherapy
16%
Patient-Data
16%
Diagnostic Test
16%
Symptomatic Treatment
15%
External Beam Radiotherapy
15%
Leiomyosarcoma
15%
Treatment Modality
15%
Long-Term Outcome
14%
Edema
14%
Distant Metastasis
14%
Cancer Registry
13%
Neoplasm
13%
Doxorubicin
13%
Vinblastine
13%
Bleomycin
13%
Adriamycin Bleomycin Vinblastine Dacarbazine
13%
Polyethylene Terephthalate
13%
Acute Kidney Injury
13%
Clinical Trial Design
13%
Metastatic Kidney Cancer
13%
Sunitinib
13%
Nephrectomy
13%
Androgen Suppression
13%